1996			1995
 Shr	loss	    $0.07     loss	 $0.14
 Net	loss		292     loss	   326
 Revs			   nil			nil
 Avg shrs		   4,025		    2,350
	  6  MONTHS
 Shr	loss	    $0.19     loss	 $0.33
 Net	loss		694     loss	   771
 Revs			   nil			nil
 Avg shrs		   3,745		    2,348
(All data above 000s except per share numbers)
NOTE: NeoPharm is a developmental stage company.
--Chicago newsdesk, 312-408-8787